| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $49.5M | +69.3% | +69.4% |
| R&D Expense | $379K | -2.1% | -62.3% |
| SG&A Expense | $16.9M | -0.2% | +1.2% |
| Operating Income | $11.5M | +242.9% | +476.6% |
| Pre-tax Income | $11.4M | +169.9% | +496.2% |
| Income Tax | -$47K | -183.9% | -206.8% |
| Net Income | $11.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $38.5M | -18.2% | +1.4% |
| Short-term Investments | $54.9M | +7.5% | +8.6% |
| Accounts Receivable | $141.3M | +131.3% | +214.4% |
| Inventory | $24.8M | -24.7% | -37.8% |
| Current Assets | $263.6M | +25.4% | +45.5% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.8M | — | — |
| Investing Cash Flow | -$13.7M | — | — |
| Financing Cash Flow | -$187K | — | — |
| +170.0% |
| +491.8% |
| EPS (Basic) | $0.12 | +170.6% | +500.0% |
| EPS (Diluted) | $0.11 | +164.7% | +466.7% |
| $319.8M |
| +16.8% |
| +15.9% |
| Current Liabilities | $166.8M | +25.8% | +85.1% |
| Long-term Debt | $39.2M | +0.3% | +0.8% |
| Total Liabilities | $214.0M | +18.6% | +47.1% |
| Stockholders' Equity | $105.8M | +13.4% | -18.9% |